Group 1 - The independent director system has become an important part of corporate governance in China's listed companies, enhancing decision-making and protecting the rights of minority investors [1] - Cai Manli served as an independent director for three A-share listed companies in 2024, receiving a total remuneration of 500,000 yuan [1] - During her tenure, Cai attended all board meetings and shareholder meetings for New Hope, Feike Electric, and Aomei Medical, voting in favor of all proposals without raising any objections [1] Group 2 - Cai Manli, born in 1973, holds a PhD from Southwestern University of Finance and Economics and has qualifications as a Chinese Certified Public Accountant and Tax Agent [2] - She has held various significant positions, including Director of the Listed Company Supervision Department at the China Securities Regulatory Commission and General Manager at Eryi Sheng Asset Management [2] - Currently, she is a senior consultant at King & Wood Mallesons and serves as an independent director for multiple companies, including New Hope, Feike Electric, and Aomei Medical [2]
A股独董观察:新希望、飞科电器、奥美医疗独董蔡曼莉报酬合计56.4万元 曾任证监会上市公司监管部处长